Provider
Interleukin-5 (IL-5) Inhibitors - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Sep 01, 2026
Prior Authorization, Quantity Limit
Program effective Date: Sep 01, 2026
Prior Authorization, Quantity Limit
Program effective Date: Sep 01, 2026
Step Therapy, Quantity Limit
Program effective Date: Sep 01, 2026
Prior Authorization
Program effective Date: Sep 01, 2026
Prior Authorization, Quantity Limit
Program effective Date: Sep 01, 2026
Prior Authorization, Quantity Limit
Program effective Date: Sep 01, 2026
Prior Authorization, Quantity Limit
Program effective Date: Sep 01, 2026
Prior Authorization, Quantity Limit
Program effective Date: Sep 01, 2026
Prior Authorization, Quantity Limit
Program effective Date: Sep 01, 2026
Prior Authorization, Quantity Limit
Program effective Date: Sep 01, 2026